Allergen, Fungi and Molds, Cephalosporium
Also known as: CEPHALOSPO
Use
This test measures the level of IgE antibodies specific to cephalosporium fungi and molds in the patient's serum. It helps in identifying allergic sensitization to cephalosporium, which could be a contributing factor in allergic diseases such as asthma, allergic rhinitis, or atopic dermatitis. The presence of IgE antibodies indicates that the patient may have an allergic reaction when exposed to the allergen, although the test result should always be considered in conjunction with the patient's clinical history and other allergy tests.
Special Instructions
Not provided.
Limitations
Results falling within the range of 0.10–0.34 kU/L should be interpreted with caution as their clinical relevance is undetermined. Even with increasing allergen-specific IgE concentrations, they may not correlate with clinical symptoms or skin test results. A negative test result does not exclude the possibility of a clinical allergy or anaphylaxis. The test should be used as part of a broader diagnostic workup including clinical evaluation and possibly other diagnostic tests.
FDA ApprovedNew York Approved
Methodology
Immunoassay (Fluorescent Enzyme Immunoassay)
Biomarkers
Cephalosporium IgE
Protein
LOINC Codes
- 6066-5 - Acremonium IgE Qn
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.25 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection.
Patient Preparation
Avoid multiple patient encounters.
Storage Instructions
Refrigerated.
Causes for Rejection
Hemolyzed, icteric, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant